On the HCPLive Addiction medicine condition center page, resources on the topics of medical news and expert insight into clinical addiction can be found. Content includes articles, interviews, videos, podcasts, and breaking news on addiction therapy research, treatment, and drug development.
April 25th 2024
FDA approves the generic equivalent of Narcan HCI Nasal Spray—naloxone hydrochloride (Naloxone HCI)—for an emergency treatment option for an opioid overdose.
Facing Regional, Financial & Access Hurdles in Opioid Addiction
Lindsey Jennings, MD, MPH, and Carolyn Bogdon, MSN, FNP-BC, of Medical University of South Carolina discuss the challenges facing health care providers who are on the front line of battling the opioid epidemic.
FDA Approves New Dosage Strength for Buprenorphine and Naloxone Film Therapy
September 8th 2018The sublingual film therapy has been approved under a 16 mg/ 4 mg dosage strength for the maintenance treatment of opioid dependence, adding to therapy options which include both brand name and generic versions.
Response to Alcohol Indicative of Future Outcomes in Those with Prior AUDs
Recent reports have suggested a higher-than-expected rate of problematic drinking among the elderly, prompting an examination of a number of factors that could be utilized as future predictors of alcohol-related outcomes.
Potentially Inappropriate Prescribing Practices Linked to Opioid Overdose Risk
Researchers identified 6 types of potentially inappropriate prescriptions, all of which were associated with higher hazards for all-cause mortality, 4 with non-fatal overdose, and 5 with fatal overdose.